NLRP3 and metabolic dysfunction-associated steatotic liver disease: Many have lipid-lowering, hypoglycemic, anti-inflammatory, and hepatoprotective effects and show significant inhibitory activities on NLRP3 inflammasome, making them valuable resources for the development of new NAFLD drugs.